Antibodies Market Analysis (2019-2027)

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. ANTIBODIES MARKET ANALYSIS - (2019-2027) • Antibodies Market, By Product Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug complexes (ADCs)), By Disease Indication (CNS Disorders, Cardiovascular Diseases, Cancer, Autoimmune Disorders), By End User (Hospitals, Long-term Care Facilities, Research institutes), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

3. Antibodies are used in therapeutic application for the treatment of diseases such as cancer, autoimmune diseases, hematological diseases, infectious diseases, and others. Increasing prevalence of cancer is expected to create lucrative opportunities for growth of manufacturers in the market. For instance, according to the National Cancer Institute, 2016, the number of new cancer cases per year is expected to increase to 23.6 million by 2030, worldwide. Antibodies products come under biologic therapeutic products. Biologic manufacturers require approval (similar to pharma drug approval) from the U.S. Food & Drug Administration prior to bringing the product in the market. However, unlike drugs, biologics require Biologics License Applications (BLA) to be filed with the Center for Biologics Evaluation and Research (CBER). Moreover, various government authorities are focused on controlling/lowering drug prices by adding reforms. 

4. For instance, the U.S. government is seeking to lower patients out-of-pocket spending in Medicare by curbing deals that drug manufacturers make with its distribution channel partners such as pharmacy benefit managers, February 2019 (these deals are responsible for increasing list price of drugs).

5. Restraints of the Global Antibodies Market • High cost of monoclonal antibodies therapies makes it unaffordable for the population in the low- and middle-income group to opt for these therapies, which in turn restrains growth of the market. For instance, Keytruda (Pembrolizumab), a monoclonal antibody for the treatment of various types of cancer, costs around US$ 2,250 for a vial of 50 mg.

6. Key features of the study: • This report provides in-depth analysis of the global antibodies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players • It profiles leading players in the global antibodies market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

7. Key companies covered as a part of this study include Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi, Eli Lilly and Co., Iovance Biotherapeutics, Inc., Ultragenyx Pharmaceutical Inc. and Kyowa Kirin Co., Ltd. • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics • The global antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

8. Detailed Segmentation • Global Antibodies Market, By Product Type: • Monoclonal antibodies • Polyclonal antibodies • Antibody-drug complexes (ADCs) • Global Antibodies Market, By Disease Indication: • CNS Disorders • Cardiovascular Diseases • Cancer • Autoimmune Disorders

9. Global Antibodies Market, By End User: • Hospitals • Long-term Care Facilities • Research institutes

10. By End User • Hospitals • Long-term Care Facilities • Research institutes • By Country: • U.S. • Canada • Europe • By Product Type • Monoclonal antibodies • Polyclonal antibodies • Antibody-drug complexes (ADCs) • Global Antibodies Market, By Geography: • North America • By Product Type • Monoclonal antibodies • Polyclonal antibodies • Antibody-drug complexes (ADCs) • Disease Indication • CNS Disorders • Cardiovascular Diseases • Cancer • Autoimmune Disorders

11. By Country: • U.K. • Germany • Italy • France • Spain • Russia • Rest of Europe • Asia Pacific • By Product Type • Monoclonal antibodies • Polyclonal antibodies • Antibody-drug complexes (ADCs) • Disease Indication • CNS Disorders • Cardiovascular Diseases • Cancer • Autoimmune Disorders • By End User • Hospitals • Long-term Care Facilities • Research institutes

12. By Country: • China • India • Japan • ASEAN • Australia • South Korea • Rest of Asia Pacific • Latin America • By Product Type • Monoclonal antibodies • Polyclonal antibodies • Antibody-drug complexes (ADCs) • Disease Indication • CNS Disorders • Cardiovascular Diseases • Cancer • Autoimmune Disorders • By End User • Hospitals • Long-term Care Facilities • Research institutes

13. Middle East: • By Product Type • Monoclonal antibodies • Polyclonal antibodies • Antibody-drug complexes (ADCs) • Disease Indication • CNS Disorders • Cardiovascular Diseases • Cancer • Autoimmune Disorders • By End User • Hospitals • Long-term Care Facilities • Research institutes • Disease Indication • CNS Disorders • Cardiovascular Diseases • Cancer • Autoimmune Disorders • By End User • Hospitals • Long-term Care Facilities • Research institutes • By Country: • Brazil • Mexico • Argentina • Rest of Latin America

14. By End User • Hospitals • Long-term Care Facilities • Research institutes • By Country/Region: • Central Africa • South Africa • North Africa • By Country: • GCC • Israel • Rest of Middle East • Africa • By Product Type • Monoclonal antibodies • Polyclonal antibodies • Antibody-drug complexes (ADCs) • Disease Indication • CNS Disorders • Cardiovascular Diseases • Cancer • Autoimmune Disorders

15. Takeda Pharmaceutical Company Limited • Amgen Inc. • Biogen Inc. • Bristol-Myers Squibb Company • AbbVie Inc. • Sanofi S.A. • Eli Lilly and Co. • Iovance Biotherapeutics, Inc. • Ultragenyx Pharmaceutical Inc. • Kyowa Kirin Co., Ltd. • “*” marked represents similar segmentation in other categories in the respective section. • Company Profiles • Novartis International AG* • Company Overview • Product Portfolio • Financial Performance • Key Strategies • Recent Developments • F. Hoffmann-La Roche Ltd. • Johnson & Johnson Services, Inc.

16. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference:https://www.coherentmarketinsights.com/market-insight/antibodies-market-2629

17. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

18. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

19. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/